# Interest of GLP1 Analogues in Overweight Type 2 Diabetic Patients With Chronic Inflammatory Bowel Disease

> **NCT05196958** · NA · UNKNOWN · sponsor: **Fondation Hôpital Saint-Joseph** · enrollment: 20 (estimated)

## Conditions studied

- Inflammatory Bowel Diseases
- Diabetes Mellitus, Type 2

## Interventions

- **OTHER:** GLP1 analogues

## Key facts

- **NCT ID:** NCT05196958
- **Lead sponsor:** Fondation Hôpital Saint-Joseph
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-25
- **Primary completion:** 2024-01-14
- **Final completion:** 2024-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05196958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05196958, "Interest of GLP1 Analogues in Overweight Type 2 Diabetic Patients With Chronic Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05196958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*